Results 131 to 140 of about 26,568 (229)

Mucoadhesive Nanostructured Lipid Carriers of Ketoconazole for Enhanced Dermal Delivery and Antifungal Activity: Formulation Optimization and In Vivo Evaluation

Pharmaceutics
Background/Objective: Topical therapy remains a cornerstone in managing fungal infections due to the deep-seated nature of the pathogens and the persistence of the disease.
Mashan Almutairi, Ahmed Adel Ali Youssef, Yazed S. Alsowaida, Ahmed Alobaida, Samir A. Ross   +4 more
doaj   +1 more source

Ketoconazole Pharmacokinetics In Sudanese Patients With Mycetoma [PDF]

, 2006
The Plasma concentration of ketoconazole was assessed by estimation of the pharmacokinetic parameters for tow regimen 400 mg and 800 mg in mycetoma patients.
Mutasim, Abdelbadie
core  

In vitro effects of N‐acetylcysteine in combination with antifungal agents against Malassezia pachydermatis isolated from canine otitis externa

Veterinary Medicine and Science
Background Many clinicians prescribe antifungal agents to treat canine otitis externa (OE). However, studies evaluating the antifungal effects of N‐acetylcysteine (NAC) and its combinations are limited.
Minhae Jeon, Seulgi Bae
doaj   +1 more source

Comparision between therapeutic efficacy of terbinafine and ketoconazole in Tinea versicolor

مجله دانشگاه علوم پزشکی گرگان, 2011
Background and Objective: Tinea versicolor is a common fungal infection of the skin caused by the dimorphic lipophilic yeast Pityrosporum orbicular (Malassezia furfur). Lesions begin as multiple small, circular macules of various colors.
Rostami Mogaddam M (MD), Didehvar R (MD), Nasimi M   +2 more
doaj  

<i>In vitro</i> evaluation of the antimicrobial activity of chlorhexidine alone or in combination with ketoconazole or miconazole against clinical isolates of <i>Malassezia pachydermatis</i> and multidrug-resistant <i>Staphylococcus pseudintermedius</i>. [PDF]

Microbiology (Reading)
Goldman G, Santoro D.
europepmc   +1 more source

Atrophying Pityriasis Versicolor: A Rare Presentation of a Common Dermatological Disorder and Literature Review. [PDF]

Case Rep Dermatol Med
Almalki AM, Jaafari SA, Hannani HY, Alattas KM, Abutaleb RA, Gamaleldin AM, Daak AK.   +6 more
europepmc   +1 more source

Development of an adult whole-body PBPK model of irinotecan and its metabolites for predicting UGT1A1/CYP3A-mediated drug-drug interactions. [PDF]

Front Pharmacol
Chen B, Li L, Xu W, Xu H, Zhu X, He Q, Zhu X, Chi-Lui Ho P, Xiang X, Ji P.   +9 more
europepmc   +1 more source

Etomidate is a potential medical option in the management of severe and refractory Cushing's syndrome. [PDF]

J Anaesthesiol Clin Pharmacol
Tharavath V, Biyani G, Vaikkakara S, Gouri RS, Mohammed S, Metta R.   +5 more
europepmc   +1 more source

Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors. [PDF]

CPT Pharmacometrics Syst Pharmacol
Riad MMH, Marroum P, Shebley M, Xiong H.
europepmc   +1 more source

Comparison of the Effectiveness of Ivermectin 1% Cream and Ketoconazole 2% Cream in Treating Facial Seborrheic Dermatitis: A Double-Blind, Randomized, Controlled Clinical Trial. [PDF]

Health Sci Rep
Sepaskhah M, Shamshiri F, Bagheri Z.
europepmc   +1 more source